跳至主要内容

Fischer Indole Synthesis Reaction

 

In 1883, E. Fischer and F. Jourdan treated pyruvate with 1-methylphenylhydrazone with HCl alcohol solution to obtain 1-methylindole-2-carboxylic acid. After this discovery, the Fischer indole synthesis reaction became a very significant method for the synthesis of substituted indoles. The Fischer indole synthesis reaction is a simple and rapid synthesis method for arylhydrazones obtained from the reaction of aldehydes or ketones with arylhydrazones. 

The drug discovery of Medicilon mainly include chemistry (synthetic chemistry, medicinal chemistry) and biology. Among them, our chemistry team can undertake multi-dimensional business cooperation such as custom synthesis of compunds, compound library construction, SAR compound synthesis and screening, compound structure and biological activity optimization.

This reaction is followed by cyclization to generate polysubstituted indoles. The phenylhydrazone generated in the reaction is heated and rearranged under acid catalysis to eliminate a molecule of ammonia to obtain 2-substituted or 3-substituted indole derivatives. In practical operation, aldehyde or ketone and equivalent phenylhydrazine can be heated to reflux in acid to obtain phenylhydrazone, which can be rearranged immediately under acid catalysis to eliminate ammonia to obtain indole compounds. The commonly used catalysts are zinc chloride, boron trifluoride, polyphosphoric acid, AcOH, HCl, trifluoroacetic acid, etc. Under the catalysis of Lewis acid, this reaction can usually be carried out under mild conditions, while protic acid usually needs to be heated to higher temperature.

In recent years, with the development of coupling reactions, people have developed a more convenient coupling reaction method. Fisher's indole synthesis method has been widely used in the field of alkaloid and pharmaceutical synthesis, even an indispensable method. A synthetic method for aryl hydrazones via the Buchwald-Hartwig coupling of aryl halides and hydrazones was also developed (modified by Buchwald).



Reaction mechanism

Aldehydes, ketones and aryl hydrazones react, and the generated aryl hydrazones are heated under an acidic catalyst, and undergo a single-electron transfer cyclization to generate substituent indoles.



Response instance

 



Synthesis of Peduncularine. Roberson, C. W.; Woerpel, K. A, J. Am. Chem. Soc. 2002, 124, 11342.


References

1. Name Reactions (A Collection of Detailed Reaction Mechanisms), Jie Jack Li, Fischer indole synthesis, pages 253-254.

2. Organic Chemistry Portal: http://www.organic-chemistry.org/namedreactions/fischer-indole-synthesis.shtm

3. Chemical station: http://www.chem-station.com/cn/reactions/2014/05/%E8%B4%B9%E8%88%8D%E5%B0%94%E5%90%B2% E5%93%9A%E5%90%88%E6%88%90-fischer-indole-synthesis.html

评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...

The Launch Meeting was Held by Medicilon and DAC Biotech of the Contract Research on ADC Preclinical Study

  Chuansha, Shanghai, Nov. 8th, 2019 — Medicilon held the launch meeting with Hangzhou DAC Biotech Co., Ltd to initiate the   preclinical study   of the antibody-drug-conjugate (ADC)  DXC005, including the   pharmacology study ,   DMPK study   and the   safety evaluation . Medicilon has previously completed integrated  preclinical research  on ADC drugs cooperating with DAC Biotech and other companies. Two of them has been approved by NMPA and entered Phase I clinical trials. About Hangzhou DAC Biotech Co., Ltd Hangzhou DAC Biotech, Co., Ltd was officially registered in HEDA Area, Hangzhou City, Zhejiang Province, China around the end of Year 2012, and is located nearby the bank of beautiful Qiantang River. The company focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drug, both of which are banded together with smart linkers. About Antibody-Drug-Conjugate (ADC) ADCs ...

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...